Skip to main content

Clifford Chance

Clifford Chance

Briefings

Greater China Healthcare and Life Sciences Bulletin: Autumn 2011

2 October 2011

In this edition, we focus on off-label drug use and promotion, and provide a comparative analysis of China's legal regime with other jurisdictions in Europe and the US.

In addition to our lead article, we have included two further legal updates on Good Manufacturing Practice (GMP) for pharmaceutical products and the Good Supply Practice (GSP) standards.

Download PDF